Processing

Please wait...

Settings

Settings

Goto Application

1. WO2020113579 - USE OF MEGAMONAS FUNIFORMIS IN PREVENTION AND/OR TREATMENT OF METABOLIC DISEASES

Publication Number WO/2020/113579
Publication Date 11.06.2020
International Application No. PCT/CN2018/119909
International Filing Date 07.12.2018
IPC
A61K 35/741 2015.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
35Medicinal preparations containing materials or reaction products thereof with undetermined constitution
66Microorganisms or materials therefrom
74Bacteria
741Probiotics
C12N 1/20 2006.01
CCHEMISTRY; METALLURGY
12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
1Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
20Bacteria; Culture media therefor
A61P 3/10 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
3Drugs for disorders of the metabolism
08for glucose homeostasis
10for hyperglycaemia, e.g. antidiabetics
A61P 3/04 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
3Drugs for disorders of the metabolism
04Anorexiants; Antiobesity agents
A61P 3/06 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
3Drugs for disorders of the metabolism
06Antihyperlipidemics
A61P 9/10 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
9Drugs for disorders of the cardiovascular system
10for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Applicants
  • 深圳华大生命科学研究院 BGI SHENZHEN [CN]/[CN]
Inventors
  • 戴莹 DAI, Ying
  • 邹远强 ZOU, Yuanqiang
  • 肖亮 XIAO, Liang
Agents
  • 深圳鼎合诚知识产权代理有限公司 DHC IP ATTORNEYS
Priority Data
Publication Language Chinese (ZH)
Filing Language Chinese (ZH)
Designated States
Title
(EN) USE OF MEGAMONAS FUNIFORMIS IN PREVENTION AND/OR TREATMENT OF METABOLIC DISEASES
(FR) UTILISATION DE MEGAMONAS FUNIFORMIS POUR LA PRÉVENTION ET/OU LE TRAITEMENT DE MALADIES MÉTABOLIQUES
(ZH) 单形巨单胞菌在预防和/或治疗代谢性疾病中的用途
Abstract
(EN)
Provided is a use of Megamonas funiformis in the prevention and/or treatment of metabolic diseases. Megamonas funiformis has the function of preventing and/or treating metabolic diseases (such as obesity, diabetes, atherosclerosis-related diseases, cardiovascular disease and hyperuricemia).
(FR)
L'invention concerne une utilisation de Megamonas funiformis pour la prévention et/ou le traitement de maladies métaboliques. Megamonas funiformis a pour fonction de prévenir et/ou traiter des maladies métaboliques (telles que l'obésité, le diabète, les maladies liées à l'athérosclérose, les maladies cardiovasculaires et l'hyperuricémie).
(ZH)
提供一种单形巨单胞菌(Megamonas funiformis)在预防和/或治疗代谢性疾病中的用途,单形巨单胞菌具有预防和/或治疗代谢性疾病(如肥胖、糖尿病、动脉粥样硬化相关疾病、心血管疾病、高尿酸血症)的作用。
Latest bibliographic data on file with the International Bureau